- Home
- OFLX vs ZBIO Comparison
OFLX vs ZBIO Comparison
Compare OFLX & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- ZBIO
- Stock Information
- Founded
- OFLX 1975
- ZBIO 2019
- Country
- OFLX United States
- ZBIO United States
- Employees
- OFLX N/A
- ZBIO N/A
- Industry
- OFLX Industrial Specialties
- ZBIO
- Sector
- OFLX Industrials
- ZBIO
- Exchange
- OFLX Nasdaq
- ZBIO NYSE
- Market Cap
- OFLX 344.9M
- ZBIO 389.2M
- IPO Year
- OFLX 2005
- ZBIO 2024
- Fundamental
- Price
- OFLX $36.37
- ZBIO $10.03
- Analyst Decision
- OFLX
- ZBIO Strong Buy
- Analyst Count
- OFLX 0
- ZBIO 7
- Target Price
- OFLX N/A
- ZBIO $32.29
- AVG Volume (30 Days)
- OFLX 72.8K
- ZBIO 223.0K
- Earning Date
- OFLX 07-30-2025
- ZBIO 08-16-2025
- Dividend Yield
- OFLX 3.74%
- ZBIO N/A
- EPS Growth
- OFLX N/A
- ZBIO N/A
- EPS
- OFLX 1.72
- ZBIO N/A
- Revenue
- OFLX $99,795,000.00
- ZBIO $15,000,000.00
- Revenue This Year
- OFLX N/A
- ZBIO $206.00
- Revenue Next Year
- OFLX N/A
- ZBIO $41.92
- P/E Ratio
- OFLX $21.14
- ZBIO N/A
- Revenue Growth
- OFLX N/A
- ZBIO N/A
- 52 Week Low
- OFLX $28.12
- ZBIO $5.83
- 52 Week High
- OFLX $57.81
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- OFLX 63.12
- ZBIO N/A
- Support Level
- OFLX $32.22
- ZBIO N/A
- Resistance Level
- OFLX $35.02
- ZBIO N/A
- Average True Range (ATR)
- OFLX 1.88
- ZBIO 0.00
- MACD
- OFLX 0.35
- ZBIO 0.00
- Stochastic Oscillator
- OFLX 86.90
- ZBIO 0.00
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.